Reaction

Medical Device Complication reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 7,402 reports · 56 co-occurring drugs

As of the last recalculation, Medical Device Complication appears in 7,402 FAERS reports alongside 56 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL (PRR 48.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Etonogestrel	743	48.6	49.3
Levonorgestrel	1,381	23.5	23.6
Copper	220	14.8	14.8
Etonogestrel And Ethinyl Estradiol	97	12.4	12.5
Epoprostenol	56	12.1	12.2
Bupivacaine	26	7.8	7.9
Bosentan	98	5.5	5.5
Insulin Human	58	4.1	4.1
Epoetin Alfa	17	4.0	4.0
Alendronate Sodium	129	3.6	3.6
Treprostinil	152	3.5	3.5
Teriparatide	126	3.2	3.2
Paricalcitol	15	3.0	3.0
Sildenafil Citrate	128	2.9	2.9
Ampicillin	8	2.7	2.7
Ampicillin Sodium	8	2.7	2.7
Clonidine	49	2.7	2.7
Dalteparin Sodium	10	2.7	2.7
Baclofen	79	2.6	2.6
Ambrisentan	114	2.6	2.6
Raloxifene Hydrochloride	13	2.5	2.5
Meperidine Hydrochloride	8	2.4	2.4
Mesna Injection	7	2.4	2.4
Mesna	7	2.3	2.3
Calcium Gluconate	10	2.3	2.3
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	7	2.2	2.2
Tolterodine Tartrate	7	2.2	2.2
Tadalafil	70	2.0	2.0
Ibuprofen And Diphenhydramine Citrate	16	1.9	1.9
Sildenafil Powder,	23	1.8	1.8
Erythropoietin	13	1.8	1.8
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	19	1.7	1.7
Insulin Lispro	84	1.7	1.7
Gefitinib	5	1.6	1.6
Agalsidase Beta	5	1.5	1.5
Multivitamin	26	1.5	1.5
Prasugrel Hydrochloride	5	1.4	1.4
Sevoflurane	4	1.4	1.4
Golimumab	41	1.3	1.3
Medroxyprogesterone Acetate	23	1.3	1.3
Risperidone	61	1.3	1.3
Miconazole Nitrate	4	1.3	1.3
Interferon Beta-1A	86	1.3	1.3
Sevelamer Carbonate	5	1.2	1.2
Temozolomide	9	1.2	1.2
Ifosfamide	9	1.2	1.2
Interferon Beta-1B	8	1.2	1.2
Paliperidone Palmitate	13	1.1	1.1
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	3	1.0	1.0
Exenatide	19	1.0	1.0
Natalizumab	60	0.9	0.9
Palivizumab	5	0.9	0.9
Cetuximab	10	0.9	0.9
Methoxy Polyethylene Glycol-Epoetin Beta	3	0.8	0.8
Somatropin	19	0.7	0.7
Cinacalcet Hydrochloride	11	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.